Efficacy, Safety, and Patient-Reported Outcomes of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Thailand: A Multicenter Prospective StudyJCO GLOBAL ONCOLOGYIF32022-12-0110OAAI
Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational studyECLINICALMEDICINEIF102022-10-018OAAI
Efficacy and patient-report outcomes of atezolizumab/bevacizumab for unresectable hepatocellular carcinoma in ThailandANNALS OF ONCOLOGYIF65.42022-07-011PRE